Okayama University, Chiba Cancer Center - Research Institute, KOTAI Biotechnologies, Inc., National Cancer Center - Division of Cancer Immunology, KOTAI Biotechnologies, Inc., National Cancer Center - Division of Cellular Signaling, National Cancer Center Research Institute, National Cancer Center - Division of Cancer Immunology, Chiba Cancer Center - Research Institute, University of Yamanashi - Department of Dermatology, Kumamoto Kenhoku Hospital, Chiba Cancer Center - Department of Thoracic Surgery, Chiba Cancer Center - Department of Thoracic Surgery, Chiba Cancer Center - Research Institute, Chiba Cancer Center - Department of Head and Neck Surgery, Chiba University - Department of Otolaryngology, Head and Neck Surgery, Nagoya University - Department of Immunology, University of Yamanashi - Department of Dermatology, Chiba University - Department of Dermatology, Osaka City University - Department of Hematology, National Cancer Center - Division of Cellular Signaling, University of Tokyo, Graduate School of Frontier Sciences, Department of Computational Biology and Medical Sciences, National Cancer Center, Japan and Chiba Cancer Center - Research Institute

Okayama University, Okayama University, Sapporo Medical University, Okayama University, Chiba Cancer Center - Research Institute, Okayama University, University of Tokyo - Graduate School of Frontier Science, University of Tokyo, Chiba University, Okayama University, Okayama University, Nagoya University, National Cancer Center Research Institute, National Cancer Center Research Institute, University of Yamanashi - Department of Dermatology, University of Yamanashi - Department of Dermatology, Kumamoto Kenhoku Hospital, Chiba University, Chiba University, KOTAI Biotechnologies, Inc., Chiba Cancer Center, Nagoya University - Graduate School of Medicine, National Cancer Center, Japan, Okayama University, Chiba University, Tokyo Medical and Dental University, University of Tokyo - Graduate School of Frontier Science, University of Tokyo, Graduate School of Frontier Sciences, Department of Computational Biology and Medical Sciences, National Cancer Center - Division of Cellular Signaling, Asahikawa Medical University, Sapporo Medical University, Chiba Cancer Center, Chiba Cancer Center - Research Institute and Independent

National Institute of Infectious Diseases - Research Center for Drug and Vaccine Development, Tokyo Shinagawa Hospital, National Institute of Infectious Diseases - Research Center for Drug and Vaccine Development, Tokyo Shinagawa Hospital, KOTAI Biotechnologies, Inc., National Institute of Infectious Diseases - Research Center for Drug and Vaccine Development, National Institute of Infectious Diseases - Research Center for Drug and Vaccine Development, National Institute of Infectious Diseases - Research Center for Drug and Vaccine Development, National Institute of Infectious Diseases - Research Center for Drug and Vaccine Development, National Institute of Infectious Diseases - Research Center for Drug and Vaccine Development, National Institute of Infectious Diseases - Research Center for Drug and Vaccine Development, National Institute of Infectious Diseases - Research Center for Drug and Vaccine Development, Tokyo Shinagawa Hospital, National Institute of Advanced Industrial Science and Technology (AIST) - Artificial Intelligence Research Center (AIRC), KOTAI Biotechnologies, Inc., National Institute of Infectious Diseases - Research Center for Drug and Vaccine Development, Tokyo Shinagawa Hospital and National Institute of Infectious Diseases - Research Center for Drug and Vaccine Development